Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

ITI Pharma and Healthcare Fund · Direct ✕Edelweiss Business Cycle Fund · Direct ✕

Growth of ₹10,000

Basics

ITI Pharma and Healthcare FundEdelweiss Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseITIEdelweiss
NAV₹20.7004₹9.5446
NAV date20 Nov 202620 Nov 2026
History5.0 years2.3 years
Expense ratio0.9%1.2%
Stars★★★★★Not rated
Growth Score72.80—

Returns

ITI Pharma and Healthcare FundEdelweiss Business Cycle Fund
1 month+11.35%+5.85%
3 months+4.42%+1.17%
6 months+12.33%+5.73%
YTD+21.31%+3.05%
1 year+18.01%+3.75%
3 years (CAGR)+19.94%—
5 years (CAGR)+15.73%—
10 years (CAGR)——
Since launch+15.56%−2.21%

Risk

ITI Pharma and Healthcare FundEdelweiss Business Cycle Fund
Volatility15.9%—
Downside volatility10.1%—
Sharpe0.85—
Sortino1.34—
Calmar1.17—
Return / risk1.25—
Deepest fall−17.69%−26.39%
Days to recover364—
Below its high+0.00%−7.61%

Against benchmark

ITI Pharma and Healthcare FundEdelweiss Business Cycle Fund
Alpha−1.30%—
Beta0.98—
R²84.6%—
Up capture94.1%—
Down capture98.8%—
Tracking error6.2%—
Information ratio−0.26—
Treynor0.13—

Consistency

ITI Pharma and Healthcare FundEdelweiss Business Cycle Fund
Best 1-year+61.91%+20.97%
Middle 1-year+15.57%+1.01%
Worst 1-year−9.32%−14.64%
1-year periods with a loss21.7%43.9%
Middle 3-year+21.36%—
Positive months72.2%—
Best day+3.48%+4.77%
Worst day−3.28%−3.85%
Worst 5% day−1.48%−2.02%
Positive days56.0%54.0%
NAVs a year247247

SIP of ₹10,000 a month

ITI Pharma and Healthcare FundEdelweiss Business Cycle Fund
5-year XIRR——
5-year value——
3-year XIRR+15.60%—
1-year XIRR+27.81%+9.07%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth